Tumor-associated mutations in CTNNB1 exon three target the N-terminal phosphorylation domain of β-catenin protein, resulting in impaired phosphorylation by GSK-3β, increased β-catenin protein stabilization, and nuclear β-catenin protein accumulation [17,19,20,21,31]. This evidence concerns the gene CTNNB1 and neoplasm.